The clinical data for orforglipron is promising, and Eli Lilly plans to submit it for FDA approval as a weight loss treatment in 2025 (and for type 2 diabetes in 2026)
Briefly, curcumin and green tea are two options for attenuating iron overload-induced oxidative damage
The peptide calculator helps researchers determine appropriate dosing based on concentration and desired amounts
Pay special attention to moles if you're a teen, pregnant, or going through menopause, times when your hormones may be surging
The Phase 2 trial used 2mg as the starting dose, and it is the lowest dose in the standard published titration: 2mg, then 4mg, then 8mg, then 12mg, each held for 4 weeks
What Will Be The Growth Driving Factors In The GLP-1 Receptor Agonist Market In The Forecast Period